Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001295
First received: November 3, 1999
Last updated: March 14, 2014
Last verified: October 2013

November 3, 1999
March 14, 2014
January 1992
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00001295 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease
Continuing Treatment for Children and Adults in the Center for Cancer Research

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Background:

It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol.

Objective:

To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol.

Eligibility:

Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol. (clinical trial)

It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH.

Design:

Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol.

No investigational treatments will be administered. This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents.

Observational
Not Provided
Not Provided
Not Provided
Not Provided
Not Provided
  • Acquired Immunodeficiency Syndrome
  • Neoplasm
  • Skin Disease
  • HIV Infections
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
2143
Not Provided
Not Provided
  • INCLUSION CRITERIA:

Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol.

It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH.

The subject or guardian signs the informed consent and agrees to the proposed treatment regimen.

EXCLUSION CRITERIA:

Subjects who have not been previously treated on a CCR research treatment protocol.

Subjects who are receiving an investigational therapy.

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00001295
920094, 92-C-0094
Not Provided
Not Provided
National Cancer Institute (NCI)
Not Provided
Principal Investigator: Caryn Steakley, R.N. National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP